Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters-Reference-Cited by-同舟云学术

Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters

Published:1994-05 Issue:1 Volume:87 Page:144-147
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Prooijen H. C. van,Visser J. J.,Oostendorp W. R. van,Gast G. C. de,Verdonck L. F.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1994.tb04884.x/fullpdf

Reference12 articles.

1. Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow Transplantation

2. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant

3. Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products

4. Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of residual risks of the transfusion-transmitted infections in Riyadh hospitals: A two-year retrospective study;Open Chemistry;2023-01-01

2. Clinical Uses of Blood Components;Transfusion Medicine;2021-03-02

3. Clinical Uses of Blood Components;Transfusion Medicine;2016-10-01

4. Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a UK dual centre experience;Transfusion Medicine;2015-06-26

5. Cytomegalovirus Infection in Pediatric Allogenic Hematopoietic Stem Cell Transplantation. A Single Center Experience;Pediatric Hematology and Oncology;2013-12-05